CGT
AGN

Capital Guardian Trust’s Allergan Inc AGN Stock Holding History

Capital Guardian Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,450
Closed -$308K – 815
2014
Q4 		$308K Sell
1,450
-300
-17% -$59.7K ﹤0.01% 303
2014
Q3 		$312K Sell
1,750
-4,083
-70% -$678K ﹤0.01% 289
2014
Q2 		$987K Sell
5,833
-37,775
-87% -$5.88M 0.01% 234
2014
Q1 		$5.41M Sell
43,608
-504,705
-92% -$61.5M 0.04% 193
2013
Q4 		$60.9M Sell
548,313
-7,061
-1% -$674K 0.4% 76
2013
Q3 		$50.2M Sell
555,374
-149,087
-21% -$13.4M 0.35% 81
2013
Q2 		$59.3M Buy
+704,461
New +$73.1M 0.41% 79

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Capital Guardian Trust's AGN Position: Q1 2015 in Review

Capital Guardian Trust sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,450 shares — an estimated $308K sold.

Capital Guardian Trust first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $60.9M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Capital Guardian Trust reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Capital Guardian Trust sold 1,450 Allergan Inc shares in Q1 2015, an estimated $308K.
  • Capital Guardian Trust first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Capital Guardian Trust's Allergan Inc position peaked at $60.9M in Q4 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Capital Guardian Trust's 13F filing for Q1 2015, filed 15 May 2015.